Release Date: 31/07/18 15:49 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 80.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%